reference/30828287

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30828287

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	173
issn	1865-3774 0925-5710
issueIdentifier	2
pageRange	165-173
publicationName	International Journal of Hematology
startingPage	165
bibliographicCitation	Takenaka T, Itoh K, Suzuki T, Utsunomiya A, Matsuda S, Chou T, Sai T, Sano M, Konda S, Ohno T, Mikuni C, Deura K, Yamada T, Mizorogi F, Nagoshi H, Tomonaga M, Hotta T, Kawano K, Tsushita K, Hirano M, Shimoyama M, Lymphoma Study Group of the Japan Clinical Oncology Group. Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301. International Journal of Hematology. 2004 Apr;79(2):165–73. doi: 10.1532/ijh97.03115.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5f28ddd7fce42debc080c5502985319 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cdf13f388f44e93437a6bf6819f90dee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6c51b5eb6f0dd819ee614d7ad55b1be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24948a61807a0bfb0ce9794b4d1e7367 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_070fe99e8de61d2c7dc19c4291dca542 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95749ab146a3883d1daf2da5d6139294 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb61550bb762067a8ec02e19217a4679 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66e7cc8693a50fddd6767f790c2e19d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27b4a5eb97c0c421d656442a680365ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30af79a365e6e1586a040aeb5f4630f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd6e77c36b727315a201d7176552d730 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01d5a65b245b21c925e3510fcaf93cf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3a42eadd33730c561ecbf252f4019a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4273d4781e23baabcefa6e80bb72292b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_643311592b8cf0a9996d24a5ae3ac7ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b514716b7716e611464dd46b0088dec7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ced5fc56ad0897d9709bdb89dbbbb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9cf09b4e819549466629193de8ee89c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2fb8b4e6bc2fdeb7258392b4af26ff1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73623e8432a68ec4e49ba71c443b4273 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10b4abe2e7e9fe2b525e5e9991c69f82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_234402e1e4a61a7b9ec4056f57f70855
date	2004-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15005346 https://doi.org/10.1532/ijh97.03115
isPartOf	https://portal.issn.org/resource/ISSN/0925-5710 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1221 https://portal.issn.org/resource/ISSN/1865-3774
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301
discusses	http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0013330 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0014925 http://id.nlm.nih.gov/mesh/M0028268 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0074857
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71741 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127406732 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 69.